注册 | 登录 | 充值

返回首页
找到约 1 条结果

ATHENA研究:决奈达隆对于房颤患者心血管事件的影响

Background: Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation.Methods: We conducted a multicenter trial to evaluate the use of dronedarone in 4628 pat..... 
学术资讯 - 临床研究